Literature DB >> 20941820

A prospective evaluation of second transurethral resection in non-muscle invasive bladder tumors.

M Aydin1, Z Tandogdu, F O Kurtulus, E Avci, A Fazlioglu, M Cek.   

Abstract

PURPOSE: In this prospective study we evaluated the benefit of a second transurethral bladder resection (TURB) for Ta-T1 bladder carcinomas.
METHODS: One hundred consecutive patients with superficial bladder tumor (Ta-T1) undergoing TURB and routine repeat TURB (Re-TURB) 4-6 weeks after the initial resection were included in the study. Re-TURB was applied to the scar of the first resection and other suspicious lesions in the bladder.
RESULTS: From January 2003 to December 2008 100 patients were enrolled onto the study (mean age 60 years). At the first TURB, 56 (56%) patients had multiple lesions and 44 (44%) had a solitary tumor. Re-TURB revealed histological residual tumors in 40 (40%) patients. Residual tumor was found in 40% of Ta and 40% of T1 disease and 29% of the tumors were found at initial site of resection. Re-TURB revealed residual tumor in 55% of patients with multiple tumors and only 20% of patients with a solitary bladder tumor.
CONCLUSION: These data suggest that tumor stage is not a good indicator to determine the necessity of Re-TURB in superficial bladder carcinomas. Routine Re-TURB is beneficial in Ta-T1 multiple bladder tumors.

Entities:  

Mesh:

Year:  2010        PMID: 20941820

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  2 in total

Review 1.  Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

Authors:  Siamak Daneshmand; Anne K Schuckman; Bernard H Bochner; Michael S Cookson; Tracy M Downs; Leonard G Gomella; H Barton Grossman; Ashish M Kamat; Badrinath R Konety; Cheryl T Lee; Kamal S Pohar; Raj S Pruthi; Matthew J Resnick; Norm D Smith; J Alfred Witjes; Mark P Schoenberg; Gary D Steinberg
Journal:  Nat Rev Urol       Date:  2014-09-23       Impact factor: 14.432

2.  Low-dose bacille Calmette-Guérin for non-muscle-invasive bladder cancer: Results of a prospective study.

Authors:  Hani H Nour; Smair E Gobashy; Ahmad M Kamal; Ahmad G Elbaz; Mamdouh A Roshdy; Ahmad I Kamel
Journal:  Arab J Urol       Date:  2015-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.